Evidence map›Paper›PMID 29805680›Full record

ArticleOncology letters2018

Exosome-encapsulated microRNA-223-3p as a minimally invasive biomarker for the early detection of invasive breast cancer.

Mio Yoshikawa, Hisae Iinuma, Yasuko Umemoto, Takako Yanagisawa, Akiko Matsumoto, Hiromitsu Jinno

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 107 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. MicroRNA Expression Profile in Early-Stage Breast Cancers.MicroRNA (Shariqah, United Arab Emirates) · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mio YoshikawaDepartment of Surgery, Teikyo University School of Medicine, Tokyo 173-0003, Japan.
Hisae IinumaDepartment of Surgery, Teikyo University School of Medicine, Tokyo 173-0003, Japan.
Yasuko UmemotoDepartment of Surgery, Teikyo University School of Medicine, Tokyo 173-0003, Japan.
Takako YanagisawaDepartment of Surgery, Teikyo University School of Medicine, Tokyo 173-0003, Japan.
Akiko MatsumotoDepartment of Surgery, Teikyo University School of Medicine, Tokyo 173-0003, Japan.
Hiromitsu JinnoDepartment of Surgery, Teikyo University School of Medicine, Tokyo 173-0003, Japan.
Teikyo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients diagnosed preoperatively with ductal carcinoma

Indexed as

biomarkerbreast cancerdetecting invasive ductal carcinomaductal carcinoma in situexosomemicroRNA-223-3p

Identifiers

PMID29805680
PMCPMC5958689
OpenAlexW2797238491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.